Corticosteroid-induced adverse psychiatric effects: incidence, diagnosis and management.
about
Oral corticosteroids for induction of remission in ulcerative colitisSteroids: pharmacology, complications, and practice delivery issuesGenetic Moderation of Stress Effects on Corticolimbic CircuitrySafety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data.The emotional consequences of corticosteroid use in hematology: preliminary findings.Central nervous system effects of natural and synthetic glucocorticoids.Relative hypo- and hypercortisolism are both associated with depression and lower quality of life in bipolar disorder: a cross-sectional study.Psychiatric side effects of non-psychiatric drugs.Acute confusion secondary to steroid eye dropsAdverse psychological effects of corticosteroids in children and adolescents.Screening electroencephalograms in autism spectrum disorders: evidence-based guideline.Treatment of neuropsychiatric syndromes in multiple sclerosis.Is there an optimal corticosteroid regimen for the management of an acute exacerbation of chronic obstructive pulmonary disease?Psychiatric co-morbidity is associated with increased risk of surgery in Crohn's disease.Psychiatric issues in multiple sclerosis.Side effects of short-term oral corticosteroids.Central nervous system involvement in adult acute lymphoblastic leukemia.Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management.Could stress cause psychosis in individuals vulnerable to schizophrenia?Suicidal ideation and suicide attempts among asthma.Beyond the joints: neurological involvement in rheumatoid arthritis.Steroid psychosis: a review for neurosurgeons.Corticosteroid-induced neuropsychiatric disorders: review and contrast with neuropsychiatric lupus.The clinical significance of drug interactions between dermatological and psychoactive medications.Prevalence and prescription patterns of oral glucocorticoids in adults: a retrospective cross-sectional and cohort analysis in FranceHomicide and associated steroid acute psychosis: a case report.Asthma severity, psychiatric morbidity, and quality of life: correlation with inhaled corticosteroid dose.A Pilot Placebo Controlled Randomized Trial of Dexamethasone for Chronic Subdural Hematoma.Progressive multiple sclerosis and mood disorders.The neuropsychiatric aspect of Addison's disease: a case reportPharmacological and non-pharmacological therapies of cognitive impairment in multiple sclerosis.Anti-SS-A (Ro) antibody is positively associated with steroid-induced psychiatric events in systemic lupus erythematosus patients.New-onset psychiatric disorders after corticosteroid therapy in systemic lupus erythematosus: an observational case-series study.Postsurgical screening for psychosocial disorders in neurooncological patients.Methods to Induce Chronic Ocular Hypertension: Reliable Rodent Models as a Platform for Cell Transplantation and Other Therapies.
P2860
Q24244780-4F445CC8-4C83-414A-BF4C-A80EDD57447CQ27015022-27D56001-3736-407B-9CBF-1871E880364CQ28606435-8AB5B939-5E46-448B-BE9B-0314A12A6FAAQ31000488-251638B2-EB0C-4A70-BE8E-3A698CF9A0DEQ33390687-A50D7F6F-18C8-4915-95C7-B64C7D1F61F9Q33507425-C0344B08-FDB1-4753-B90A-4EF3C8FC1A62Q33763259-B0574FC9-AD19-4860-A5B1-432A1EE2536AQ34138808-9CFB4A24-68E5-48D0-8872-2F51CD587E16Q34799891-3F8DF9B8-7370-46CB-9B1F-54DB62CF3863Q35283601-D4CFA8D0-7AA4-491E-8312-6CF94A53560AQ36099191-EC5A77F3-0B8A-4607-9A4C-1E27FA55BE23Q36153396-B520DFBD-8BC1-431B-B74C-06F3FBF3D046Q36428410-25F844E6-1632-4889-AD1E-FE8514B64438Q36553624-7A702884-EC52-4393-838B-05DCF25C7904Q36972200-166CA7EF-ACD7-47AB-A59C-18FEB66BC181Q37112046-3826A4CF-25BF-4F93-B93E-242527CA2913Q37293534-D98D9017-85A9-48FF-9B7E-0FCCF6C8FA15Q37374868-3ABC0111-621A-473F-8763-D408608E591FQ37415050-ACD6B0A9-B41B-4CD3-922C-CB346D159CBEQ37455402-60767350-10AA-47F4-A43C-AD9538B84A06Q37935613-8D79F555-6520-4EFB-9CC0-0333FE3BC4E9Q38024049-54F4F6B0-FEFA-4B39-9196-28C499A7C5DFQ38099203-1765D4F5-BF48-4B23-84B6-3083EFA124C0Q38185684-3A96664F-9EEF-47ED-9D6B-CE2CD5F4C8CBQ38650895-1B5E2954-BBEF-4CE9-BF93-69C2A90CA224Q39487719-4FCD14AC-6C65-4E5A-AA41-30D00545F8B3Q39668045-7676C1AC-77B3-4AB3-8A31-EF0271B4372AQ40016634-5CD4F880-9229-4BDC-AD74-C2D8B296C50AQ41033035-451C7A57-ACD4-4DDB-BF54-4DDC792CEF3FQ42217445-AC383E0C-B2D9-4F5E-9A3A-31E1DB83A922Q47978062-3EC5CC15-879D-4330-8588-596B43CFAADBQ48210362-43F97385-C4EB-4B0F-AF12-D9F6528821F3Q48229388-674FCF2D-6141-44D4-9EE8-DF0DFE32C28CQ48420499-4F26C0E5-F913-429F-91B3-8F7D0C28396DQ52594562-8485F569-9488-408D-BCF0-E65EC9027650
P2860
Corticosteroid-induced adverse psychiatric effects: incidence, diagnosis and management.
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Corticosteroid-induced adverse psychiatric effects: incidence, diagnosis and management.
@ast
Corticosteroid-induced adverse psychiatric effects: incidence, diagnosis and management.
@en
type
label
Corticosteroid-induced adverse psychiatric effects: incidence, diagnosis and management.
@ast
Corticosteroid-induced adverse psychiatric effects: incidence, diagnosis and management.
@en
prefLabel
Corticosteroid-induced adverse psychiatric effects: incidence, diagnosis and management.
@ast
Corticosteroid-induced adverse psychiatric effects: incidence, diagnosis and management.
@en
P2860
P1433
P1476
Corticosteroid-induced adverse psychiatric effects: incidence, diagnosis and management
@en
P2093
C I Neutel
P2860
P304
P356
10.2165/00002018-200022020-00004
P577
2000-02-01T00:00:00Z
P6179
1012655038